Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

The paper reports the results from the observational retrospective-prospective RUBINO study conducted in Italy to assess the safety of rituximab in the treatment of rheumatoid arthritis (RA) in routine clinical practice. The percentage of patients who manifested at least one grade 3 or 4 adverse eve...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: PAGEPress Publications 2014-11-01
Sarja:Reumatismo
Aiheet:
Rituximab, Rheumatoid arthritis Anti-TNF failures, Safety.
Linkit:http://www.reumatismo.org/index.php/reuma/article/view/748
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia